Journal of Clinical Toxicology

Journal of Clinical Toxicology
Open Access

ISSN: 2161-0495

+44 1478 350008

Journal of Clinical Toxicology : Citations & Metrics Report

Articles published in Journal of Clinical Toxicology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical Toxicology has got h-index 20, which means every article in Journal of Clinical Toxicology has got 20 average citations.

Following are the list of articles that have cited the articles published in Journal of Clinical Toxicology.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

29 31 33 63 34 34 33 33 56 51 47 60 57 17

Research, Review articles and Editorials

12 21 26 64 18 17 24 19 39 25 36 43 46 11

Research communications, Review communications, Editorial communications, Case reports and Commentary

13 10 17 34 21 17 9 14 28 24 11 11 16 6

Conference proceedings

6 0 6 0 0 0 77 51 198 98 83 95 65 0

Citations received as per Google Scholar, other indexing platforms and portals

257 331 376 432 400 358 353 269 239 196 79 32 10 0
Journal total citations count 2911
Journal impact factor 5.72
Journal 5 years impact factor 8.04
Journal cite score 9.78
Journal h-index 20
Journal h-index since 2019 16
Important citations (838)

mutations in ski in shprintzen-goldberg syndrome lead to attenuated tgf-? responses through ski stabilization.

mutations in ski in shprintzen-goldberg syndrome lead to attenuated tgf-? responses through ski stabilization

tgf?1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.

epigallocatechin gallate (egcg) suppresses epithelial-mesenchymal transition (emt) and invasion in anaplastic thyroid carcinoma cells through blocking of tgf-?1/smad signaling pathways

safety and activity of the tgf? receptor i kinase inhibitor galunisertib plus the anti-pd-l1 antibody durvalumab in metastatic pancreatic cancer

clinical evaluation of unselected cardiac arrest survivors in a tertiary center over a 1-year period (the lazaruz study)

effect of ramosetron on qtc interval: a randomised controlled trial in patients undergoing off-pump coronary artery bypass surgery

clinical development of galunisertib (ly2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

first-in-human dose study of the novel transforming growth factor-? receptor i kinase inhibitor ly2157299 monohydrate in patients with advanced cancer and glioma

selective inhibition of tgf?1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape.

stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ecm interactions.

phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor i, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma.

global anti-tumor immunity after localized, bioengineered treg depletion

phase 1 study of galunisertib, a tgf-beta receptor i kinase inhibitor, in japanese patients with advanced solid tumors.

paraphenylenediamine hepatotoxic effects in adult female albino rats

a mini review: ethical usage of animals in pharmacological research

effect of zinc oxide addition on antimicrobial and antibiofilm activity of hydroxyapatite: a potential nanocomposite for biomedical applications

Sorption of ni(ii), pb(ii) and cu(ii) ions from aqueous solutions by cellulose grafted with poly(hema-co-aac): kinetic, isotherm and thermodynamic study

intake of heavy metals through milk and toxicity assessment

Impact of birth weight and neonatal nutritional interventions with micronutrients and bovine colostrum on the development of piglet immune response during the peri-weaning period.

Top